| For: | Zhou F, Wu NZ, Xie Y, Zhou XJ. Intestinal barrier in inflammatory bowel disease: A bibliometric and knowledge-map analysis. World J Gastroenterol 2023; 29(36): 5254-5267 [PMID: 37901448 DOI: 10.3748/wjg.v29.i36.5254] |
|---|---|
| URL: | https://www.wjgnet.com/2218-5836/full/v29/i36/5254.htm |
| Number | Citing Articles |
| 1 |
George Chigozie Njoku, Cathal Patrick Forkan, Fumie Mitani Soltysik, Peter Lindberg Nejsum, Flemming Pociot, Reza Yarani. Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy. Bioactive Materials 2025; 45 doi: 10.1016/j.bioactmat.2024.11.004
|
| 2 |
Hang Yuan, Gang Chen, Xuejun Sun, Junhui Yu. Mechanistic evidence for dibutyl phthalate as an environmental trigger for inflammatory bowel disease. iScience 2026; 29(2) doi: 10.1016/j.isci.2025.114619
|
| 3 |
Tong An, Daqin Li, Ning Wang, Feifei Ma, Tuo Li, Ningning He, Huijuan Song, Qiang Liu. Mechanisms and potential of mesenchymal stem cell-derived exosomes for treating radiation-induced intestinal injury. Extracellular Vesicle 2025; 5 doi: 10.1016/j.vesic.2025.100078
|
| 4 |
Yan-Dong Miao, Fang Zhang, Tong-Tong Zhang, Xiao-Dong Chen, Zhe Yang, Wen-Yu Luan. Intestinal barrier in inflammatory bowel disease: A bibliometric analysis. World Journal of Gastroenterology 2023; 29(45): 6017-6021 doi: 10.3748/wjg.v29.i45.6017
Abstract(862) |
Core Tip(930) |
Full Article(HTML)(2955)
|
Full Article (PDF)-1592K(245)
|
Full Article with Cover (PDF)-5517K(209)
|
Full Article (Word)-1072K(39)
|
Full Article (XML)-35K(156)
|
Audio-934K(7)
|
Peer-Review Report-320K(192)
|
Answering Reviewers-84K(154)
|
Supplementary Material-84K(160)
|
Times Cited (2)
|
Total Visits (4166)
|
Open
|
| 5 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 6 |
Jinwen Sima, Bing Zhang. The mutational landscape better corroborates effective treatment strategies for the tumor microenvironment of breast cancer. In Silico Research in Biomedicine 2025; 1 doi: 10.1016/j.insi.2025.100058
|
| 7 |
Min Zhang, Xue Song, Shengbao Liu, Nuo Zhang, Ming Yang, Pengcheng Gao, Zhijun Geng, Lugen Zuo, Xiaofeng Zhang, Lian Wang, Yueyue Wang, Jing Li, Jianguo Hu. Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway. International Immunopharmacology 2024; 134 doi: 10.1016/j.intimp.2024.112181
|
| 8 |
Wenjing Liang, Wen Zhang, Jiayi Tian, Xinping Zhang, Xinyi Lv, Ao Qu, Jinyu Chen, Zijian Wu. Advances in carbohydrate-based nanoparticles for targeted therapy of inflammatory bowel diseases: A review. International Journal of Biological Macromolecules 2024; 281 doi: 10.1016/j.ijbiomac.2024.136392
|
| 9 |
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao. Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1441785
|
| 10 |
Ali Ouchi, Yuh-Shan Ho. Some comments on using of Web of Science Core Collection for bibliometric studies in volume 29 of the <i>World Journal of Gastroenterology</i>. World Journal of Methodology 2025; 15(4): 102000 doi: 10.5662/wjm.v15.i4.102000
|
| 11 |
Liheng Kang, Chunsheng Feng, Ziyi Tang, Wanping Gu, Ying Wang, Aiyue Pei, Meihua Piao. Pueraria flavones attenuate DSS-induced colitis by regulating the microbiota-bile acid-FXR/TGR5 axis and suppressing mtDNA-cGAS-STING signaling. iScience 2026; 29(4) doi: 10.1016/j.isci.2026.115275
|
| 12 |
Yu Liang, Zhen Meng, Xue-Li Ding, Man Jiang. Effects of proton pump inhibitors on inflammatory bowel disease: An updated review. World Journal of Gastroenterology 2024; 30(21): 2751-2762 doi: 10.3748/wjg.v30.i21.2751
|